Ras interacts with many downstream effectors that regulate complex cytoplasmic signaling networks. In this issue, Gupta et al. (2007) use mouse models of Ras-mediated tumorigenesis to show that the interaction of Ras with a single isoform of phosphatidylinositol 3-kinase (PI3K), called p110α (PIK3CA), is critical for tumor formation. This result will stimulate re-evaluation of pharmacological approaches to target Ras for cancer treatment
Summary: RAS family GTPases contribute directly to the regulation of type I phosphoinositide 3-kinas...
Direct interaction of RAS with the PI3K p110α subunit mediates RAS-driven tumor development: however...
Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly ha...
Ras interacts with many downstream effectors that regulate complex cytoplasmic signaling networks. I...
SummaryRas proteins signal through direct interaction with a number of effector enzymes, including t...
SummaryRAS proteins directly activate PI3-kinases. Mice bearing a germline mutation in the RAS bindi...
Ras proteins mediate PI3K activation through direct binding to p110 catalytic subunits. However, it ...
The genetic alterations in cancer cells are tightly linked to signaling pathway dysregulation. Ras i...
<p>The Ras proteins, composed of H, N, and KRas, are a family of small GTPases that normally transmi...
Ras proteins are essential mediators of a multitude of cellular processes, and its deregulation is f...
The spectrum of tumors associated with oncogenic Ras in humans often differs from those in mice eith...
RAS family GTPases contribute directly to the regulation of type I phosphoinositide 3-kinases (PI3Ks...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
Ras proteins signal through direct interaction with a number of effector enzymes, including type I p...
Summary: RAS family GTPases contribute directly to the regulation of type I phosphoinositide 3-kinas...
Direct interaction of RAS with the PI3K p110α subunit mediates RAS-driven tumor development: however...
Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly ha...
Ras interacts with many downstream effectors that regulate complex cytoplasmic signaling networks. I...
SummaryRas proteins signal through direct interaction with a number of effector enzymes, including t...
SummaryRAS proteins directly activate PI3-kinases. Mice bearing a germline mutation in the RAS bindi...
Ras proteins mediate PI3K activation through direct binding to p110 catalytic subunits. However, it ...
The genetic alterations in cancer cells are tightly linked to signaling pathway dysregulation. Ras i...
<p>The Ras proteins, composed of H, N, and KRas, are a family of small GTPases that normally transmi...
Ras proteins are essential mediators of a multitude of cellular processes, and its deregulation is f...
The spectrum of tumors associated with oncogenic Ras in humans often differs from those in mice eith...
RAS family GTPases contribute directly to the regulation of type I phosphoinositide 3-kinases (PI3Ks...
RAS mutations are the most common gain-of-function change in human cancer and promise to be a critic...
SummaryOncogenic mutations in the small GTPase Ras are highly prevalent in cancer, but an understand...
Ras proteins signal through direct interaction with a number of effector enzymes, including type I p...
Summary: RAS family GTPases contribute directly to the regulation of type I phosphoinositide 3-kinas...
Direct interaction of RAS with the PI3K p110α subunit mediates RAS-driven tumor development: however...
Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly ha...